Onward Medical N.V.
EBR:ONWD.BR
5.84 (EUR) • At close February 19, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.077 | 0.208 | -0.396 | 0.464 | 0.593 | 0.482 | 0.813 | 0.586 | 0.589 | 0.211 | 0.277 | 0.277 | 0.237 | 0.237 |
| Cost of Revenue
| 0.486 | 6.681 | 6.762 | 0.329 | 0.392 | 0.343 | 7.344 | 4.635 | 4.331 | 3.801 | 0.419 | 0.419 | 0.521 | 0.521 |
| Gross Profit
| -0.409 | -6.473 | -7.158 | 0.135 | 0.201 | 0.139 | -6.531 | -4.049 | -3.742 | -3.59 | -0.142 | -0.142 | -0.284 | -0.284 |
| Gross Profit Ratio
| -5.312 | -31.12 | 18.076 | 0.291 | 0.338 | 0.288 | -8.033 | -6.91 | -6.353 | -17.014 | -0.513 | -0.513 | -1.196 | -1.196 |
| Reseach & Development Expenses
| 6.308 | 6.134 | 6.203 | 7.638 | 6.923 | 6.215 | 6.769 | 3.849 | 3.019 | 2.804 | 2.678 | 2.678 | 2.361 | 2.361 |
| General & Administrative Expenses
| 0 | 7.148 | 4.751 | 3.288 | 2.884 | 2.398 | 7.511 | 3.156 | 2.964 | 1.691 | 1.124 | 1.124 | 0.623 | 0.623 |
| Selling & Marketing Expenses
| 0 | 1.387 | 1.375 | 0.784 | 0.542 | 0.434 | 1.163 | 0.353 | 0.227 | 0.167 | 0.131 | 0.131 | 0.049 | 0.049 |
| SG&A
| 10.85 | 9.587 | 6.791 | 11.741 | 10.794 | 9.509 | 9.344 | 3.831 | 3.553 | 1.858 | 1.254 | 1.254 | 0.672 | 0.672 |
| Other Expenses
| 0 | -3.445 | -3.469 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.035 | 1.035 | 0.649 | 0.649 |
| Operating Expenses
| 17.158 | 12.276 | 9.525 | 19.379 | 17.717 | 15.724 | 12.293 | 5.775 | 5.143 | 3.09 | 4.967 | 4.967 | 3.682 | 3.682 |
| Operating Income
| -17.567 | -18.749 | -16.683 | -19.708 | -18.109 | -16.067 | -18.706 | -9.824 | -8.833 | -6.68 | -5.386 | -5.386 | -4.203 | -4.203 |
| Operating Income Ratio
| -228.143 | -90.139 | 42.129 | -42.474 | -30.564 | -33.369 | -23.009 | -16.765 | -14.997 | -31.659 | -19.444 | -19.444 | -17.732 | -17.732 |
| Total Other Income Expenses Net
| 0.372 | 0.179 | -0.154 | 0.471 | 0.531 | 0.107 | -2.784 | -2.931 | -2.385 | -2.096 | -1.336 | -1.336 | -0.745 | -0.745 |
| Income Before Tax
| -17.195 | -18.57 | -16.837 | -19.237 | -17.578 | -15.96 | -21.49 | -12.755 | -11.218 | -8.776 | -6.722 | -6.722 | -4.947 | -4.947 |
| Income Before Tax Ratio
| -223.312 | -89.279 | 42.518 | -41.459 | -29.668 | -33.146 | -26.433 | -21.766 | -19.046 | -41.592 | -24.267 | -24.267 | -20.873 | -20.873 |
| Income Tax Expense
| 0.278 | -0.318 | 0.062 | 0.045 | -0.801 | 0.035 | 0.053 | 0.016 | 0.008 | 0.028 | 0.02 | 0.02 | 0.009 | 0.009 |
| Net Income
| -17.473 | -18.252 | -16.899 | -19.282 | -16.777 | -15.995 | -21.543 | -12.771 | -11.21 | -8.804 | -6.742 | -6.742 | -4.956 | -4.956 |
| Net Income Ratio
| -226.922 | -87.75 | 42.674 | -41.556 | -28.316 | -33.219 | -26.498 | -21.794 | -19.032 | -41.725 | -24.338 | -24.338 | -20.911 | -20.911 |
| EPS
| -0.39 | -0.53 | -0.56 | -0.64 | -0.56 | -0.53 | -1.46 | -3.24 | -2.96 | -2.58 | -0.32 | -0.32 | -0.24 | -0.24 |
| EPS Diluted
| -0.39 | -0.53 | -0.56 | -0.64 | -0.56 | -0.53 | -1.44 | -3.24 | -2.96 | -2.58 | -0.32 | -0.32 | -0.24 | -0.24 |
| EBITDA
| -15.649 | -18.315 | -16.569 | -18.451 | -16.47 | -14.761 | -18.68 | -9.7 | -8.815 | -6.557 | -5.27 | -5.27 | -4.087 | -4.087 |
| EBITDA Ratio
| -203.234 | -88.053 | 41.84 | -39.765 | -27.797 | -30.656 | -22.977 | -16.553 | -14.966 | -31.076 | -19.025 | -19.025 | -17.243 | -17.243 |